Stock Comparison

TWST vs UNH

Twist Bioscience Corp vs UnitedHealth Group Inc

The Verdict

TWST takes this one.

Winner

TWST

Twist Bioscience Corp

7.5

out of 10

Solid Pick

UNH

UnitedHealth Group Inc

0.3

out of 10

Distressed

Head-to-Head

$2.9B

Market Cap

$276.2B

N/A

P/E Ratio

22.9

-19.6%

Profit Margin

2.7%

-16.6%

Return on Equity

12.5%

0.2

Debt-to-Equity

0.0

Aggressive

Overall Risk

Moderate-High

7.5

DVR Score

0.3

The Deep Dive

TWST7.5/10

Twist Bioscience (TWST) continues to be a high-risk, high-reward investment with significant 10x growth potential within 3-5 years. The company's unique silicon-based DNA synthesis platform maintains its position for future market leadership in synthetic biology and DNA data storage. Recent Q1 fiscal 2026 results showed robust revenue growth (17% YoY), an improved gross margin (52.0%), and narrowe...

Full TWST Analysis

UNH0.3/10

UnitedHealth Group (UNH) remains a healthcare titan, but its sheer scale and the highly regulated nature of its operations fundamentally limit its 10x growth potential within 3-5 years. The recent Optum Health operating loss of $278M in 2025 (compared to $7.77B income in 2024) is a significant concern, eroding the growth narrative that Optum once provided. Furthermore, the proposed 0.09% Medicare ...

Full UNH Analysis

Want More Comparisons?

Run any stock through our deep value analyzer.

Analyze Any Stock →

Not Financial Advice

This comparison is for educational purposes only. We are not financial advisors. Always do your own research and consult a qualified advisor before investing.